Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia
about
Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Saprochaete capitata fungal infection in renal transplant recipient.Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study.Reply to "Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?".Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
P2860
Q38254290-E654EC7D-BE8F-4F2E-9CCC-354C1EE47D13Q38620631-255F32BD-0545-4F71-B8F5-1E43E72CB44BQ40413834-70A32673-C9C0-4392-AB89-7DA56463DE03Q40691888-D624E06C-FD09-4032-A045-74077AE74341Q40722341-70956E90-B9B7-4CB3-AD55-AB88BF7065DAQ42797931-207BCD69-2081-495C-AA03-EA430246E8A1Q47205373-AD96A6D9-9AE6-42A6-B8AD-BB10D6C97031Q47232101-B557525E-9831-45A2-9291-36CF64C14778Q48155956-7148BF33-591E-4305-B8A5-3ED55CE4A1D6Q50049061-E4C0FBC3-59F7-4789-8F9E-60D49EB0DD5CQ50113587-6265123B-E1D6-43BB-B3CD-02D270F9360C
P2860
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effectiveness of primary anti- ...... rapy of acute myeloid leukemia
@en
Effectiveness of primary anti- ...... apy of acute myeloid leukemia.
@nl
type
label
Effectiveness of primary anti- ...... rapy of acute myeloid leukemia
@en
Effectiveness of primary anti- ...... apy of acute myeloid leukemia.
@nl
prefLabel
Effectiveness of primary anti- ...... rapy of acute myeloid leukemia
@en
Effectiveness of primary anti- ...... apy of acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Effectiveness of primary anti- ...... rapy of acute myeloid leukemia
@en
P2093
Dimitrios P Kontoyiannis
Marisa Z R Gomes
Russell E Lewis
Victor E Mulanovich
Ying Jiang
P2860
P304
P356
10.1128/AAC.01527-13
P407
P577
2014-03-03T00:00:00Z